Kensaku Kasuga

3.6k total citations
74 papers, 1.2k citations indexed

About

Kensaku Kasuga is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Kensaku Kasuga has authored 74 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Physiology, 25 papers in Molecular Biology and 25 papers in Neurology. Recurrent topics in Kensaku Kasuga's work include Alzheimer's disease research and treatments (35 papers), Dementia and Cognitive Impairment Research (17 papers) and Parkinson's Disease Mechanisms and Treatments (14 papers). Kensaku Kasuga is often cited by papers focused on Alzheimer's disease research and treatments (35 papers), Dementia and Cognitive Impairment Research (17 papers) and Parkinson's Disease Mechanisms and Treatments (14 papers). Kensaku Kasuga collaborates with scholars based in Japan, United States and Poland. Kensaku Kasuga's co-authors include Takeshi Ikeuchi, Masatoyo Nishizawa, Takayoshi Tokutake, Osamu Onodera, Akinori Miyashita, Ryozo Kuwano, Toshiyuki Tezuka, Masataka Kikuchi, Norikazu Hara and Tsuyoshi Uchiyama and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Kensaku Kasuga

64 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kensaku Kasuga Japan	19	572	420	386	279	203	74	1.2k
Nobutaka Sakae Japan	23	547 1.0×	517 1.2×	807 2.1×	342 1.2×	329 1.6×	53	1.8k
Erika Bereczki Sweden	22	623 1.1×	510 1.2×	192 0.5×	280 1.0×	191 0.9×	40	1.4k
Teemu Natunen Finland	18	481 0.8×	453 1.1×	164 0.4×	168 0.6×	215 1.1×	44	1.1k
Hiroyuki Hatsuta Japan	26	914 1.6×	914 2.2×	856 2.2×	283 1.0×	327 1.6×	48	2.2k
Chang‐En Yu United States	18	840 1.5×	713 1.7×	223 0.6×	248 0.9×	193 1.0×	30	1.5k
Olivia Belbin Spain	18	875 1.5×	550 1.3×	248 0.6×	174 0.6×	264 1.3×	51	1.4k
Siegfried Kösel Germany	20	451 0.8×	621 1.5×	374 1.0×	300 1.1×	338 1.7×	35	1.3k
Milène Vandal Canada	25	890 1.6×	473 1.1×	275 0.7×	382 1.4×	351 1.7×	41	1.9k
Yuka A. Martens United States	17	748 1.3×	459 1.1×	178 0.5×	176 0.6×	490 2.4×	29	1.4k
John F. Ervin United States	17	542 0.9×	384 0.9×	181 0.5×	239 0.9×	194 1.0×	27	1.0k

Countries citing papers authored by Kensaku Kasuga

Since Specialization

Citations

This map shows the geographic impact of Kensaku Kasuga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kensaku Kasuga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kensaku Kasuga more than expected).

Fields of papers citing papers by Kensaku Kasuga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kensaku Kasuga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kensaku Kasuga. The network helps show where Kensaku Kasuga may publish in the future.

Co-authorship network of co-authors of Kensaku Kasuga

This figure shows the co-authorship network connecting the top 25 collaborators of Kensaku Kasuga. A scholar is included among the top collaborators of Kensaku Kasuga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kensaku Kasuga. Kensaku Kasuga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sato, Kenichiro, Yoshiki Niimi, Ryoko Ihara, et al.. (2025). Immediate reactions to amyloid PET disclosure in Japanese older adults without dementia. Alzheimer s & Dementia Translational Research & Clinical Interventions. 11(4). e70167–e70167.

Yasuno, Fumihiko, Atsushi Watanabe, Yasuyuki Kimura, et al.. (2025). Plasma IL-6 Levels as a Biomarker for Behavioral Changes in Alzheimer’s Disease. NeuroImmunoModulation. 32(1). 233–244.

Tsukie, Tamao, Kiyoshi Onda, Yasuo Miyagi, et al.. (2025). Association of Plasma Placental Growth Factor with White Matter Hyperintensities in Alzheimer’s Disease. Biomolecules. 15(10). 1367–1367.

Kasuga, Kensaku, et al.. (2024). Alzheimer’s Disease-Related Cerebrospinal Fluid Biomarkers in Progressive Supranuclear Palsy. Brain Sciences. 14(9). 859–859. 1 indexed citations

Kimura, Atsushi, Masahiro Hatakeyama, Masaki Watanabe, et al.. (2024). A case of cerebral amyloid angiopathy with ipsilateral tau and contralateral amyloid PET uptake related to cadaveric dura mater implanted in childhood. European Journal of Nuclear Medicine and Molecular Imaging. 52(8). 2737–2739.

Yasuno, Fumihiko, Yasuyuki Kimura, Aya Ogata, et al.. (2024). Trait-anxiety and glial-related neuroinflammation of the amygdala and its associated regions in Alzheimer's disease: A significant correlation. Brain Behavior & Immunity - Health. 38. 100795–100795. 2 indexed citations

Kasuga, Kensaku, Noriko Isoo, Toshihiro Hayashi, et al.. (2023). Soluble form of the APP fragment, sAPPβ, positively regulates tau secretion. Neuroscience Research. 193. 63–70. 2 indexed citations

Kommaddi, Reddy Peera, Aditi Verma, Graciela Muñiz‐Terrera, et al.. (2023). Sex difference in evolution of cognitive decline: studies on mouse model and the Dominantly Inherited Alzheimer Network cohort. Translational Psychiatry. 13(1). 123–123. 11 indexed citations

Yasuno, Fumihiko, Yasuyuki Kimura, Aya Ogata, et al.. (2023). Neuroimaging biomarkers of glial activation for predicting the annual cognitive function decline in patients with Alzheimer’s disease. Brain Behavior and Immunity. 114. 214–220. 6 indexed citations

10.

Kasuga, Kensaku, Tamao Tsukie, Masataka Kikuchi, et al.. (2023). The clinical application of optimized AT(N) classification in Alzheimer’s clinical syndrome (ACS) and non-ACS conditions. Neurobiology of Aging. 127. 23–32. 15 indexed citations

11.

Kasuga, Kensaku, Masataka Kikuchi, Tamao Tsukie, et al.. (2022). Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid. BMJ Neurology Open. 4(2). e000321–e000321. 11 indexed citations

12.

Nosheny, Rachel L., Rebecca E. Amariglio, Sietske A.M. Sikkes, et al.. (2022). The role of dyadic cognitive report and subjective cognitive decline in early ADRD clinical research and trials: Current knowledge, gaps, and recommendations. Alzheimer s & Dementia Translational Research & Clinical Interventions. 8(1). e12357–e12357. 23 indexed citations

13.

Sun, Yang, Yuan Gao, Tomohisa Nakamura, et al.. (2022). Presenilin Is Essential for ApoE Secretion, a Novel Role of Presenilin Involved in Alzheimer's Disease Pathogenesis. Journal of Neuroscience. 42(8). 1574–1586. 17 indexed citations

14.

Kandiah, Nagaendran, Seong Hye Choi, Chaur‐Jong Hu, et al.. (2022). Current and Future Trends in Biomarkers for the Early Detection of Alzheimer’s Disease in Asia: Expert Opinion. Journal of Alzheimer s Disease Reports. 6(1). 699–710. 14 indexed citations

15.

Hirose, Genjiro, et al.. (2021). Follow-up study of a patient with early onset cerebral amyloid angiopathy following childhood cadaveric dural graft. Acta Neurochirurgica. 163(5). 1451–1455. 13 indexed citations

16.

Nakajima, Madoka, Masakazu Miyajima, Ikuko Ogino, et al.. (2018). Preoperative Phosphorylated Tau Concentration in the Cerebrospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus. Journal of Alzheimer s Disease. 66(1). 319–331. 24 indexed citations

17.

Hara, Norikazu, Masataka Kikuchi, Akinori Miyashita, et al.. (2017). Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer’s disease. Acta Neuropathologica Communications. 5(1). 10–10. 127 indexed citations

18.

Suzuki, Yuji, Yukihiro Nakamura, Kenichi Yamada, et al.. (2015). Reduced CSF Water Influx in Alzheimer’s Disease Supporting the β-Amyloid Clearance Hypothesis. PLoS ONE. 10(5). e0123708–e0123708. 28 indexed citations

19.

Uchiyama, Tsuyoshi, Takeshi Ikeuchi, Yasuomi Ouchi, et al.. (2008). PROMINENT PSYCHIATRIC SYMPTOMS AND GLUCOSE HYPOMETABOLISM IN A FAMILY WITH A SNCA DUPLICATION. Neurology. 71(16). 1289–1291. 26 indexed citations

20.

Kasuga, Kensaku, Hiroyuki Kaneko, Masatoyo Nishizawa, Osamu Onodera, & Takeshi Ikeuchi. (2007). Generation of intracellular domain of insulin receptor tyrosine kinase by γ-secretase. Biochemical and Biophysical Research Communications. 360(1). 90–96. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact